A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don’t know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
Developed by engineers in London, the £10 device can be used at home and could revolutionise kidney disease care in the UK, which currently costs the NHS over £1.4 billion – more than breast, lung, colon and skin cancer combined.
Created by Bio Nano Consulting, the device – called quantitative electrochemical lateral flow assay (QELFA) – uses nanoparticles to test the patient’s urine giving results in seconds and is linked to their surgery via mobile technology so doctors can track how the disease is developing.
The quantitative electrochemical lateral flow assay (QELFA) device (courtesy of Somersault 18:24)
Source: Institution of Mechanical Engineers